Compounds, compositions and methods

By providing small molecule calcitonin and amylin receptor modulators, these receptors are activated, solving the problem of poor regulatory effects in existing technologies and achieving effective treatment for obesity and diabetes.

CN122319145APending Publication Date: 2026-06-30ACONCAGUA BIOTECH
View PDF 43 Cites 0 Cited by

Patent Information

Application Number
CN202480058356.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-06-06
Filing Date
2024-07-12
Publication Date
2026-06-30

AI Technical Summary

Technical Problem

Existing technologies have difficulty effectively modulating calcitonin and amylin receptors, resulting in poor efficacy of therapies for metabolic disorders such as obesity and diabetes.

Method used

We provide small molecule calcitonin and amylin receptor modulators, including compounds and pharmaceutical compositions, for activating these receptors to improve metabolic function.

Benefits of technology

By activating calcitonin and amylin receptors, it significantly improves glycemic regulation and weight management, providing an effective treatment for obesity and diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122319145A_ABST
    Figure CN122319145A_ABST
Patent Text Reader

Abstract

This application discloses compounds of formula I for modulating the activity of calcitonin receptors and / or amylin receptors, as well as pharmaceutical compositions comprising the compounds disclosed herein. Methods for treating diseases or disorders related to calcitonin receptors and / or amylin receptors are also provided.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Reduced moisture chemical reactions

    IN256918B

  • Anti-nausea drug combinations

    US10071088B2

  • Combinations of amisulpride and another anti-emetic for treating nausea and vomiting

    US10322106B2

  • Use of amisulpride as an anti-emetic

    US10525033B2

  • Compositions and methods for treating centrally mediated nausea and vomiting

    US10828297B2